Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

338.99 296.15 361.51 389.32
Gross Profit
338.99 296.15 361.51 389.32
Operating Income
123.19 98.50 200.18 234.17
EBT
93.57 70.03 171.47 207.38
Income after Tax
28.55 24.02 102.18 129.87
Net Income Common
28.55 24.02 102.18 129.87
Gross Margin
100.00% 100.00% 100.00% 100.00%
EBIT Margin
36.34% 33.26% 55.37% 60.15%
Net Profit Margin
8.42% 8.11% 28.26% 33.36%
Free Cash Flow Margin
19.96% 42.89% 31.04% 47.66%
EBITDA
125.09 100.38 202.03 236.00
EBIT
123.19 98.50 200.18 234.17

Show all line items

In millions of $ except per-share values · columns are period end dates